Research
Fat molecules called polyunsaturated fatty acids, or PUFAs, can help lessen nerve damage in amyotrophic lateral sclerosis (ALS), according to a study of fruit flies and cell models. Previous studies…
Recently studies have shown ALS in the United States to be more commonly diagnosed in White males over 60 years of age. Previous epidemiologic studies addressing racial variation in ALS…
ALS affects individuals across all backgrounds, yet representation in ALS research has long been skewed. Data reveals that approximately 95% of participants in previous ALS clinical trial studies were Caucasian,…
Biotech company aims to develop molecules that restore RNA processing Biotech company Auttx has received a $125,000 grant to advance the development of new molecules that aim to restore normal…
The National Institutes of Health (NIH) is dedicated to improving the health and well-being of people with disabilities through research, training, and career development to promote health equity and inclusion…
LOS ANGELES, Oct. 23, 2024 /PRNewswire/ — The ALS Network, formerly ALS Golden West, has awarded a $125,000 grant through its global research program to AUTTX, LLC. to help develop…
Neuvivo, a late-clinical stage biopharmaceutical company, today announced it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for NP001 (sodium chlorite infusion) to treat…
Diagnostics company to accelerate search for sporadic ALS therapies September 12, 2024 – FOR IMMEDIATE RELEASE LOS ANGELES – The ALS Network, formerly ALS Golden West, has awarded a $100,000…
In recognition of July as Disability Pride Month, the NIH Chief Officer for Scientific Workforce Diversity, Dr. Marie Bernard, discussed the importance of disability inclusion with Dr. Alison Cernich, Deputy…
The U.S. Food and Drug Administration has announced the establishment of a Rare Disease Innovation Hub. The Hub will connect and engage the rare disease community; help the community navigate…